Song X J
Department of Ophthalmology, Third Teaching Hospital, Hebei Medical College, Shijiazhuang.
Zhonghua Yan Ke Za Zhi. 1990 Sep;26(5):289-92.
Flow cytometry (FCM) is a new technic that determines with precision the cellular DNA content and its distribution in various phases of the cell cycle. Using FCM, we analysed paraffin embedded tissue masses of retinoblastoma from 20 patients with the results that the rate of occurrence of DNA heteroploid was 35%; the occurrence rate of heteroploid in the glaucoma stage and the extraocular stage was higher than that in the intraocular stage (P less than 0.02); the postoperative survival rate of the diploid and near-diploid tumors was obviously higher than that of the heteroploid (P = 0.01); the cellular proportion in the G2M stage of the heteroploid and the index of cell proliferation was obviously higher than that of the diploid and near-diploid (P less than 0.05). This technique is of value in estimating the prognosis of retinoblastoma.
流式细胞术(FCM)是一种能精确测定细胞DNA含量及其在细胞周期各阶段分布的新技术。我们运用FCM分析了20例视网膜母细胞瘤石蜡包埋组织块,结果显示DNA异倍体发生率为35%;青光眼期和眼外期异倍体发生率高于眼内期(P<0.02);二倍体及近二倍体肿瘤术后生存率明显高于异倍体(P = 0.01);异倍体G2M期细胞比例及细胞增殖指数明显高于二倍体及近二倍体(P<0.05)。该技术对评估视网膜母细胞瘤的预后具有重要价值。